
Slow Wave gets FDA dual clearance on the Slow Wave DS8™ for obstructive sleep apnea & bruxism marketed as BROSA™
The Slow Wave DS8™ oral appliance therapy (OAT), initially FDA cleared for the prescription treatment of Obstructive Sleep Apnea (OSA) in 2021 (K191320) has now


